AI-Based Mobile Intervention on Medication Non-Adherence and Transition
Recruiting
N/A
Interventional Study
Epilepsy
Seizure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 14 – 24
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 200 (estimated)
- Sponsor
- University of Central Florida · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA.
Outcomes are organized into primary (effectiveness), secondary (u…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with epilepsy
* Currently prescribed anti-seizure medicine (ASMs)
* Identified as part of an underserved population, defined as meeting at least one of the following: member of a racial or ethnic group historically underrepresented in research or healthcare or low-in…
Contacts